NCT01094483View on ClinicalTrials.gov

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Platelet Inhibition

Interventions

DRUG

PN400

naproxen 500 mg/esomeprazole 20 mg oral tablet

DRUG

ASA

Asprin 81 mg enteric coated tablet

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

POZEN

INDUSTRY

lead

AstraZeneca

INDUSTRY